| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,000 |
19,176 |
$964K |
| 52000 |
|
3,530 |
3,504 |
$496K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,690 |
7,436 |
$482K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,670 |
4,639 |
$404K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,730 |
2,715 |
$299K |
| 51700 |
|
4,591 |
4,009 |
$249K |
| 51798 |
|
3,774 |
3,743 |
$166K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
264 |
254 |
$62K |
| 99223 |
Prolong inpt eval add15 m |
334 |
331 |
$34K |
| 99205 |
Prolong outpt/office vis |
165 |
165 |
$26K |
| 99222 |
Initial hospital care, per day, moderate complexity |
82 |
82 |
$8K |
| 51702 |
|
174 |
171 |
$7K |
| 96402 |
|
332 |
323 |
$6K |
| 99255 |
|
12 |
12 |
$1K |
| 51710 |
|
14 |
12 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
52 |
44 |
$915.97 |
| 99233 |
Prolong inpt eval add15 m |
15 |
14 |
$774.21 |
| 74485 |
|
12 |
12 |
$402.65 |
| 74410 |
|
12 |
12 |
$281.34 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
18 |
12 |
$23.12 |